New Publications

We constantly update the database in order to offer our customers the broadest possible choice of market research reports and meet all their needs. Browse the most recent publications below.


2017 Peru Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Pakistan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Oman Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 New Zealand Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with ... portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. Opportunities and Strategic Recommendations New product development opportunities with potentially significant ...

Jan, 2017 1120 pages
2017 Myanmar Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Mexico Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Malaysia Tumor Marker Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five ... 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing ...

Jan, 2017 1120 pages
2017 Lebanon Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Kuwait Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Jordan Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Israel Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Iraq Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Iran Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Indonesia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 India Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Hong Kong Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights Five-year test volume and sales forecasts Feature comparison of major ...

Jan, 2017 1120 pages
2017 Croatia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Colombia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 China Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Chile Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Brazil Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Bangladesh Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Bahrain Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 Argentina Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive... US$ 4,250.00

... , including: Infectious Diseases Forensic Testing Cancer  Paternity Testing/HLA Typing Genetic Diseases Others Five-year test volume and sales projections ... molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

Jan, 2017 1120 pages
2017 North America Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology,... US$ 9,700.00

... new report from VPGMarketResearch.com provides granular analysis of the North America diagnostic testing market, including Canada, Mexico, and USA. For each country ... market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine Function Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...

Jan, 2017 181 pages
2017 Vietnam Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Venezuela Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 United Arab Emirates Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales... US$ 4,850.00

... is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock ... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric ...

Jan, 2017 535 pages
2017 Thailand Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Taiwan Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 South Korea Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... - over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines ...

Jan, 2017 535 pages
2017 South Africa Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... - over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines ...

Jan, 2017 535 pages
2017 Singapore Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Serbia Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Saudi Arabia Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... - over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines ...

Jan, 2017 535 pages
2017 Qatar Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Philippines Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Peru Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Pakistan Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Oman Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Nigeria Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 New Zealand Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of ... - over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines ...

Jan, 2017 535 pages
2017 Myanmar Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Morocco Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Mexico Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Malaysia Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Lebanon Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Kuwait Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Kenya Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
2017 Jordan Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts,... US$ 4,850.00

... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report- over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...

Jan, 2017 535 pages
Skip to top